Negotiation Process, Drug Development Costs, and Profit Margins

4min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Exploring the impact of negotiations between Medicare and drug companies, including the possibility of a high excise tax for drug companies that refuse to engage. The chapter highlights the significance of profit margins for drug companies to sustain research and development costs, emphasizing the potential consequences of reducing these margins on drug development investment.

The Biden administration uses Medicare to cram down pricing on drug companies while claiming to help patients – but the law of unintended consequences is undefeated; the National Archives reveals there are 5,400 emails from Biden using pseudonyms; and Hurricane Idalia prepares to make landfall.

Click here to join the member exclusive portion of my show: https://utm.io/ueSEj

Ep.1799

- - -

DailyWire+:

Watch the latest episode of Master’s Program with Dennis Prager: https://bit.ly/3NvHehC

Get your Ben Shapiro merch here: https://bit.ly/3TAu2cw

- - -

Today’s Sponsors:

ExpressVPN - Get 3 Months FREE of ExpressVPN: https://expressvpn.com/ben

Balance of Nature - Start your journey to better health! For a limited time, get 40% off your first order as a preferred customer. Use promo code SHAPIRO at checkout: https://www.balanceofnature.com/

Legacybox - Shop Legacybox with my exclusive discount: https://www.legacybox.com/shapiro

ZipRecruiter - Try ZipRecruiter for FREE: https://www.ziprecruiter.com/dailywire

- - -

Socials:

Follow on Twitter: https://bit.ly/3cXUn53

Follow on Instagram: https://bit.ly/3QtuibJ

Follow on Facebook: https://bit.ly/3TTirqd

Subscribe on YouTube: https://bit.ly/3RPyBiB